Heart failure leads to specific changes in cardiac perfusion, metabolism, and innervation. Typically, in the early phase of heart failure, left ventricular (LV) efficiency of forward work is compromised and right ventricular oxidative metabolism increased while resting myocardial perfusion is normal. With advan-cing disease, LV perfusion and especially the perfusion reserve and oxidative metabolism also become compromised. In addition to the abnormalities linked with the heart failure itself, commonly co-existing left bundle branch block leads to striking, mainly regional imbalance in these parameters. Recent studies have documented that cardiac resynchronization therapy (CRT) has prominent effects on myo-cardial perfusion, metabolism, and ...
Cardiac resynchronisation therapy is a cornerstone in the treatment of advanced dyssynchronous heart...
Although neurohumoral antagonism has successfully reduced heart failure morbidity and mortality, the...
CRT has evolved as a successful treatment strategy in selected patients with drug refractory heart f...
Since its development in the 1990s, cardiac resynchronisation therapy has evolved to occupy a key po...
Better understanding of pathophysiological changes, induced by left bundle branch block (LBBB), may ...
ObjectivesWe studied whether functional improvement after cardiac resynchronization therapy (CRT) is...
OBJECTIVIES AND BACKGROUND. Cardiac resynchronization therapy (CRT) is an established treatment...
In patients treated with CRT no data relative to the relationship between regional wall motion and p...
Background—Cardiac resynchronization therapy (CRT) is widely applied in patients with heart failure ...
The genesis of cardiac resynchronisation therapy (CRT) consists of 'bedside' research and 'bench' st...
AIMS: To assess changes in cardiac adrenergic activity with cardiac resynchronization therapy (CRT),...
Aims To assess whether response to cardiac resynchronization therapy (CRT) is related to myocardial ...
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established therapy for advanced congesti...
AbstractObjectivesThe effects of long-term cardiac resynchronization therapy (CRT) on left ventricul...
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established therapy for advanced congesti...
Cardiac resynchronisation therapy is a cornerstone in the treatment of advanced dyssynchronous heart...
Although neurohumoral antagonism has successfully reduced heart failure morbidity and mortality, the...
CRT has evolved as a successful treatment strategy in selected patients with drug refractory heart f...
Since its development in the 1990s, cardiac resynchronisation therapy has evolved to occupy a key po...
Better understanding of pathophysiological changes, induced by left bundle branch block (LBBB), may ...
ObjectivesWe studied whether functional improvement after cardiac resynchronization therapy (CRT) is...
OBJECTIVIES AND BACKGROUND. Cardiac resynchronization therapy (CRT) is an established treatment...
In patients treated with CRT no data relative to the relationship between regional wall motion and p...
Background—Cardiac resynchronization therapy (CRT) is widely applied in patients with heart failure ...
The genesis of cardiac resynchronisation therapy (CRT) consists of 'bedside' research and 'bench' st...
AIMS: To assess changes in cardiac adrenergic activity with cardiac resynchronization therapy (CRT),...
Aims To assess whether response to cardiac resynchronization therapy (CRT) is related to myocardial ...
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established therapy for advanced congesti...
AbstractObjectivesThe effects of long-term cardiac resynchronization therapy (CRT) on left ventricul...
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established therapy for advanced congesti...
Cardiac resynchronisation therapy is a cornerstone in the treatment of advanced dyssynchronous heart...
Although neurohumoral antagonism has successfully reduced heart failure morbidity and mortality, the...
CRT has evolved as a successful treatment strategy in selected patients with drug refractory heart f...